Tommy Andersson
Affiliations: | Translational Medicine | University of Lund, Lund, Skåne län, Sweden |
Google:
"Tommy Andersson"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mehdawi LM, Ghatak S, Chakraborty P, et al. (2023) LGR5 Expression Predicting Poor Prognosis Is Negatively Correlated with WNT5A in Colon Cancer. Cells. 12 |
| Yadav V, Jobe N, Satapathy SR, et al. (2022) Increased MARCKS Activity in BRAF Inhibitor-Resistant Melanoma Cells Is Essential for Their Enhanced Metastatic Behavior Independent of Elevated WNT5A and IL-6 Signaling. Cancers. 14 |
| Jobe NP, Åsberg L, Andersson T. (2021) Reduced WNT5A signaling in melanoma cells favors an amoeboid mode of invasion. Molecular Oncology |
| Mohapatra P, Yadav V, Toftdahl M, et al. (2020) WNT5A-Induced Activation of the Protein Kinase C Substrate MARCKS Is Required for Melanoma Cell Invasion. Cancers. 12 |
| Osman J, Bellamkonda K, Liu Q, et al. (2019) The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer. Anticancer Research. 39: 1719-1728 |
| Mohapatra P, Prasad CP, Andersson T. (2018) Combination therapy targeting the elevated interleukin-6 level reduces invasive migration of BRAF inhibitor-resistant melanoma cells. Molecular Oncology |
| Prasad CP, Manchanda M, Mohapatra P, et al. (2018) WNT5A as a therapeutic target in breast cancer. Cancer Metastasis Reviews |
| Prasad CP, Andersson T. (2018) Abstract B021: Inhibition of β-catenin impairs triple-negative breast cancer (TNBC) cell migration and invasion by modulating aerobic glycolysis components Molecular Cancer Therapeutics. 17 |
| Prasad CP, Södergren K, Andersson T. (2017) Reduced production and uptake of lactate are essential for the ability of WNT5A signaling to inhibit breast cancer cell migration and invasion. Oncotarget. 8: 71471-71488 |
| Canesin G, Evans-Axelsson S, Hellsten R, et al. (2017) Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model. Plos One. 12: e0184418 |